Joerg Zehetner, Johanna Hoffsten, Shuchesmita Das, Sebastian F. Schoppmann, John C. Lipham
{"title":"Looking back on a gold standard: a systematic literature review of laparoscopic Nissen fundoplication as an anti-reflux treatment option","authors":"Joerg Zehetner, Johanna Hoffsten, Shuchesmita Das, Sebastian F. Schoppmann, John C. Lipham","doi":"10.1007/s10353-024-00836-z","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Laparoscopic Nissen fundoplication is considered the gold standard in surgical management of gastroesophageal reflux disease. Therefore, exhaustive scrutiny of the procedure is necessary. The aim of this study was to perform a complete and systematic literature review of laparoscopic Nissen fundoplication to summarize the evidence for safety and efficacy over time.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>MEDLINE, Embase, CINAHL, the Cochrane Library, and Web of Science were searched for randomized controlled trials investigating intra- and postoperative outcomes at follow-ups between 4–6 weeks and 17 years.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Among 1675 screened articles, 63 articles were identified comprising 40 trials with a total of 2619 participants. Intraoperative events included bleeding (2.9%), gastroesophageal injury/perforation (0.9%), and spleen injury/splenectomy (0.9%). One-year clinical follow-up presented the following: dysphagia (22.4%), heartburn or epigastric/sternal pain (15.1%), gas bloating (30.1%), and inability to vomit/belch (16.4%). These outcomes displayed a U-shaped curve with a minimum of symptoms at 1 year. At 10 years postoperatively, clinical outcomes deteriorated, demonstrating dysphagia (45.3%), heartburn or epigastric/sternal pain (30.9%), inability to vomit/belch (48.8%), and gas bloating (44.4%). Furthermore, the surgical benefit seems to dissipate at 17 years. At 1 and 10 years after surgery, reoperation rates were 6.7% and 16.3%, whereas proton pump inhibitor (PPI) use was at 12.3% and 23.3%, respectively.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>The performance of Nissen fundoplication declines over time, as demonstrated by increased PPI medication usage for recurrent symptoms and an increased reoperation rate reaching a combined 39.6%, representing failures after 10 years. The complication rates are dominated by dysphagia, gas bloating, inability to belch/vomit, and/or recurrent reflux symptoms with heartburn.</p>","PeriodicalId":12253,"journal":{"name":"European Surgery","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s10353-024-00836-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Laparoscopic Nissen fundoplication is considered the gold standard in surgical management of gastroesophageal reflux disease. Therefore, exhaustive scrutiny of the procedure is necessary. The aim of this study was to perform a complete and systematic literature review of laparoscopic Nissen fundoplication to summarize the evidence for safety and efficacy over time.
Methods
MEDLINE, Embase, CINAHL, the Cochrane Library, and Web of Science were searched for randomized controlled trials investigating intra- and postoperative outcomes at follow-ups between 4–6 weeks and 17 years.
Results
Among 1675 screened articles, 63 articles were identified comprising 40 trials with a total of 2619 participants. Intraoperative events included bleeding (2.9%), gastroesophageal injury/perforation (0.9%), and spleen injury/splenectomy (0.9%). One-year clinical follow-up presented the following: dysphagia (22.4%), heartburn or epigastric/sternal pain (15.1%), gas bloating (30.1%), and inability to vomit/belch (16.4%). These outcomes displayed a U-shaped curve with a minimum of symptoms at 1 year. At 10 years postoperatively, clinical outcomes deteriorated, demonstrating dysphagia (45.3%), heartburn or epigastric/sternal pain (30.9%), inability to vomit/belch (48.8%), and gas bloating (44.4%). Furthermore, the surgical benefit seems to dissipate at 17 years. At 1 and 10 years after surgery, reoperation rates were 6.7% and 16.3%, whereas proton pump inhibitor (PPI) use was at 12.3% and 23.3%, respectively.
Conclusion
The performance of Nissen fundoplication declines over time, as demonstrated by increased PPI medication usage for recurrent symptoms and an increased reoperation rate reaching a combined 39.6%, representing failures after 10 years. The complication rates are dominated by dysphagia, gas bloating, inability to belch/vomit, and/or recurrent reflux symptoms with heartburn.
背景腹腔镜尼森胃底折叠术被认为是外科治疗胃食管反流病的金标准。因此,有必要对该手术进行详尽的审查。本研究旨在对腹腔镜尼森胃底折叠术进行全面、系统的文献综述,总结其安全性和有效性方面的证据。研究方法在MEDLINE、Embase、CINAHL、Cochrane图书馆和Web of Science中检索了随访4-6周至17年、调查术中和术后结果的随机对照试验。术中事件包括出血(2.9%)、胃食管损伤/穿孔(0.9%)和脾脏损伤/脾切除(0.9%)。一年的临床随访结果如下:吞咽困难(22.4%)、胃灼热或上腹部/胸骨疼痛(15.1%)、胃胀气(30.1%)和无法呕吐/嗳气(16.4%)。这些结果呈 U 型曲线,1 年时症状最少。术后 10 年,临床结果恶化,表现为吞咽困难(45.3%)、胃灼热或上腹部/胸骨疼痛(30.9%)、无法呕吐/腹痛(48.8%)和胃胀气(44.4%)。此外,手术带来的益处似乎在 17 年后就会消失。结论随着时间的推移,尼森胃底折叠术的效果会逐渐下降,这表现在因症状复发而使用 PPI 药物的情况增多,以及再手术率上升,合计达到 39.6%,即 10 年后的失败率。并发症主要是吞咽困难、胃胀、无法嗳气/呕吐和/或伴有胃灼热的复发性反流症状。